Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Venkatesan Jay
Elicio Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yekaterina Chudnovsky(19.99%),GKCC, LLC(19.95%)
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Chudnovsky Yekaterina
Elicio Therapeutics | 8-K: Current report
Elicio Therapeutics | 424B5: Prospectus
Elicio Therapeutics | 424B5: Prospectus
Elicio Therapeutics | 8-K: Current report
Elicio Therapeutics | EFFECT: Others
Elicio Therapeutics | EFFECT: Others
Elicio Therapeutics | CORRESP: CORRESP
Elicio Therapeutics | CORRESP: CORRESP
Elicio Therapeutics | UPLOAD: Others
Elicio Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Elicio Therapeutics | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
Elicio Therapeutics | CORRESP: CORRESP
Elicio Therapeutics | 8-K: Current report
Elicio Therapeutics | 10-Q: Quarterly report
Elicio Therapeutics | 8-K: Current report
Elicio Therapeutics | 10-K/A: Annual report (Amendment)
Elicio Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
No Data